FibroGen, Inc.
FGENNASDAQHealthcare
$9.07
$-0.15(-1.63%)
Market Cap$36692186
P/E Ratio—
52W High$21.95
52W Low$4.85
FibroGen, Inc. (FGEN) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · FGEN · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $6.44M | $29.62M | $46.80M | $140.73M | $235.31M |
| Cost of Revenue | $0.00M | $15.56M | $3.96M | $20.28M | $449.19M |
| Gross Profit | $0.00M | $14.06M | $42.84M | $120.45M | ($213.88M) |
| Gross Margin %(computed) | 0.00% | 47.47% | 91.53% | 85.59% | -90.89% |
| Operating Expenses | |||||
| R&D Expenses | $23.52M | $95.69M | $266.47M | $296.79M | $387.04M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $51.23M | $164.48M | $365.56M | $421.48M | $74.65M |
| Operating Income | ($45.90M) | ($150.42M) | ($322.72M) | ($301.02M) | ($288.53M) |
| Operating Margin %(computed) | -712.66% | -507.80% | -689.53% | -213.90% | -122.62% |
| Interest Income | $0.00M | $5.30M | $7.59M | $7.60M | — |
| Interest Expense | ($8.76M) | $8.25M | $8.10M | $1.44M | $1.07M |
| Income Before Tax | ($58.29M) | ($153.37M) | ($323.22M) | ($293.30M) | ($289.68M) |
| Income Tax Expense | ($0.09M) | ($0.27M) | ($0.25M) | $0.36M | $0.35M |
| Net Income | $183.45M | ($47.58M) | ($284.23M) | ($293.65M) | ($290.02M) |
| Net Margin %(computed) | — | -160.63% | -607.29% | -208.66% | -123.25% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $45.37 | $-0.48 | $-2.92 | $-3.15 | $-3.15 |
| Wtd Avg Shares | 4.04M | 100.04M | 97.30M | 93.58M | 92.35M |
| EBITDA | ($45.90M) | ($142.43M) | ($305.20M) | ($282.82M) | ($333.72M) |
| EBITDA Margin %(computed) | -712.66% | -480.83% | -652.09% | -200.96% | -141.82% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more FibroGen, Inc. data
About FibroGen, Inc. (FGEN) Income Statement
FibroGen, Inc. (FGEN) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, FGEN reported revenue of $0.01B, gross profit of $0.00B (gross margin 0.00%), and net income of $0.18B — a net profit margin of 2848.63%.
Frequently asked questions
FGEN · 4 questionsFibroGen, Inc. (FGEN) reported revenue of $0.01B for 2025, down 78.3% year-over-year.
FGEN revenueFGEN salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09